Abstract: The present application relates to novel opioid receptor antagonists and agonists, methods of making these compounds, and methods of use thereof.
Type:
Grant
Filed:
March 9, 1999
Date of Patent:
May 31, 2005
Assignee:
Research Triangle Institute
Inventors:
Frank I. Carroll, James B. Thomas, S. Wayne Mascarella
Abstract: Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
Type:
Application
Filed:
December 17, 2004
Publication date:
May 5, 2005
Applicant:
Research Triangle Institute
Inventors:
Monroe Wall, Mansukh Wani, Govindarajan Manikumar, Michael Wall
Abstract: The disclosure relates to zinc oxide-based sorbents, and processes for preparing and using them. The sorbents are preferably used to remove one or more reduced sulfur species from gas streams. The sorbents comprise an active zinc component, optionally in combination with one or more promoter components and/or one or more substantially inert components. The active zinc component is a two phase material, consisting essentially of a zinc oxide (ZnO) phase and a zinc aluminate (ZnAl2O4) phase. Each of the two phases is characterized by a relatively small crystallite size of typically less than about 500 Angstroms. Preferably the sorbents are prepared by converting a precursor mixture, comprising a precipitated zinc oxide precursor and a precipitated aluminum oxide precursor, to the two-phase, active zinc oxide containing component.
Type:
Application
Filed:
September 26, 2003
Publication date:
March 31, 2005
Applicant:
Research Triangle Institute
Inventors:
Santosh Gangwal, Brian Turk, Raghubir Gupta
Abstract: Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
Type:
Application
Filed:
June 30, 2003
Publication date:
December 30, 2004
Applicant:
Research Triangle Institute
Inventors:
Monroe E. Wall, Mansukh C. Wani, Govindarajan Manikumar, Michael A. Wall
Abstract: Compounds are provided that are amide analogs of SR141716A having unique CB1 receptor selectivity and providing WIN sparing binding characteristics, pharmaceutical compositions containing the compounds and their use in a method of treatment of CB1 receptor related disorders, such as obesity, schizophrenia, memory dysfunction and marijuana abuse.
Type:
Grant
Filed:
April 15, 2002
Date of Patent:
November 30, 2004
Assignee:
Research Triangle Institute
Inventors:
Brian F. Thomas, Herbert H. Seltzman, Maria Elena Y. Francisco
Abstract: Camptothecin compounds which are effective anti-tumor compounds are disclosed. These conjugates inhibit the enzyme topoisomerase I and enhance the stability of the topoisomerase I-DNA cleavable complex.
Type:
Grant
Filed:
November 16, 2000
Date of Patent:
November 30, 2004
Assignees:
Research Triangle Institute, Duke University, National Institutes of Health
Inventors:
Michael P. Gamcsik, David J. Adams, O. Michael Colvin, Monroe E. Wall, Mansukh C. Wani, Govindarajan Manikumar, Yves Pommier
Abstract: The disclosure is directed to sorbent compositions for removing reduced sulfur species (e.g., H2S, COS and CS2) a feed stream. The sorbent is formed from a multi-phase composition including a zinc titanate phase and a zinc oxide-aluminate phase. The sorbent composition is substantially free of unreacted alumina.
Type:
Grant
Filed:
April 3, 2000
Date of Patent:
November 2, 2004
Assignees:
Research Triangle Institute, Intercat, Inc.
Inventors:
Albert A. Vierheilig, Raghubir P. Gupta, Brian S. Turk
Abstract: The present application relates to novel opioid receptor antagonists and agonists, methods of making these compounds, and methods of use thereof.
Type:
Application
Filed:
December 23, 2003
Publication date:
July 29, 2004
Applicant:
Research Triangle Institute
Inventors:
Frank I. Carroll, James B. Thomas, S. Wayne Mascarella
Abstract: Hexahydroindenopyridine compounds are provided which act as spermicides and/or fungicides, spermicidal and/or fungicidal compositions containing the same, and methods for killing motile sperm and/or fungi using the compounds and compositions.
Type:
Application
Filed:
January 24, 2003
Publication date:
July 29, 2004
Applicant:
Research Triangle Institute
Inventors:
Clarence Edgar Cook, Carol Delta Sloan, Brian Frazier Thomas, Hernan Andres Navarro
Abstract: A method is provided for the preparation of metal/porous substrate composite membranes by flowing a solution of metal to be plated over a first surface of a porous substrate and concurrently applying a pressure of gas on a second surface of the porous substrate, such that the porous substrate separates the solution of metal from the gas, and the use of the resulting membrane for the production of highly purified hydrogen gas.
Abstract: A cascade thermoelectric cooler designed to cool to cryogenic temperatures of 30 to 120 K integrates high performance\high-ZT BixSb2−xTe3 and Bi2Te3−xSe3-based super-lattice-structure thin-film thermoelectric devices with a bulk-material based thermoelectric cooler including plural cascaded cold stages with each successive cascaded cold stage able to cool to a progressively lower temperature. Each cold stage in the bulk-material thermoelectric cooler includes a heat source plate, a heat sink plate, a p-type thermoelectric, and a n-type thermoelectric. Moreover, the thin-film thermoelectric cooler can have multiple stages in which each stage contains a heat source plate, a heat sink plate, a p-type super-latticed thermoelectric element, and a n type super-latticed thermoelectric element.
Abstract: The invention relates to novel compounds which show high affinity for cocaine receptors in the brain, particularly dopamine and serotonin transporter sites. The compounds may be used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases or in determining the doses of therapeutic agents that occupy significant numbers of receptors.
Type:
Grant
Filed:
September 20, 2001
Date of Patent:
March 16, 2004
Assignee:
Research Triangle Institute
Inventors:
Frank I. Carroll, Michael J. Kuhar, John W. Boja, Anita H. Lewin, Philip Abraham
Abstract: A method and system for ensuring statistical disclosure limitation (SDL) of categorical or continuous micro data, while maintaining the analytical quality of the micro data. The new SDL methodology exploits the analogy between (1) taking a sample (instead of a census,) along with some adjustments, including imputation, for missing information, and (2) releasing a subset, instead of the original data set, along with some adjustments for records still at disclosure risk. Survey sampling reduces monetary cost in comparison to a census, but entails some loss of information. Similarly, releasing a subset reduces disclosure cost in comparison to the full database, but entails some loss of information. Thus, optimal survey sampling methods can be used for statistical disclosure limitation. The method includes partitioning the database into risk strata, optimal probabilistic substitution, optimal probabilistic subsampling, and optimal sampling weight calibration.
Abstract: A method is provided for removal of sulfur gases and recovery of elemental sulfur from sulfur gas containing supply streams, such as syngas or coal gas, by contacting the supply stream with a catalyst, that is either an activated carbon or an oxide based catalyst, and an oxidant, such as sulfur dioxide, in a reaction medium such as molten sulfur, to convert the sulfur gases in the supply stream to elemental sulfur, and recovering the elemental sulfur by separation from the reaction medium.
Type:
Application
Filed:
July 15, 2002
Publication date:
January 22, 2004
Applicant:
Research Triangle Institute
Inventors:
Santosh K. Gangwal, Apostolos A. Nikolopoulos, Thomas P. Dorchak, Mary Anne Dorchak
Abstract: A thermoelectric device and method of manufacturing the device, where thermoelectric elements of opposite conductivity type are located on respective opposing sides of a heat source member. Heat sinks are disposed on opposite sides of the thermoelectric elements. Peltier metal contacts are positioned between the thermoelectric elements and each of the heat source member and heat sinks. A plurality of devices may be arranged together in a thermally parallel, electrically series arrangement, or in a thermally parallel, electrically parallel arrangement. The arrangement of the elements allow the direction of current flow through the pairs of elements to be substantially the same as the direction of current flow through the metal contacts.
Type:
Application
Filed:
April 15, 2003
Publication date:
December 18, 2003
Applicant:
Research Triangle Institute
Inventors:
Rama Venkatasubramanian, Edward P. Siivola
Abstract: A cascade thermoelectric cooler designed to cool to cryogenic temperatures of 30 to 120 K integrates high performance\high-ZT BixSb2−xTe3 and Bi2Te3−xSe3-based super-lattice-structure thin-film thermoelectric devices with a bulk-material based thermoelectric cooler including plural cascaded cold stages with each successive cascaded cold stage able to cool to a progressively lower temperature. Each cold stage in the bulk-material thermoelectric cooler includes a heat source plate, a heat sink plate, a p-type thermoelectric, and a n-type thermoelectric. Moreover, the thin-film thermoelectric cooler can have multiple stages in which each stage contains a heat source plate, a heat sink plate, a p-type super-latticed thermoelectric element, and a n type super-latticed thermoelectric element.